|
AbCellera Biologics Inc.
|
1.1 Million USD
|
57.927%
|
|
Alkermes plc
|
186.4 Million USD
|
99.75%
|
|
Agenus Inc.
|
1.00 USD
|
-46574700.0%
|
|
Alnylam Pharmaceuticals, Inc.
|
89.14 Million USD
|
99.478%
|
|
Aptorum Group Limited
|
- USD
|
-Infinity%
|
|
Ardelyx, Inc.
|
12.44 Million USD
|
96.258%
|
|
Arrowhead Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Bicycle Therapeutics plc
|
- USD
|
-Infinity%
|
|
BioXcel Therapeutics, Inc.
|
1.99 Million USD
|
76.607%
|
|
ChromaDex Corporation
|
14.52 Million USD
|
96.793%
|
|
Chimerix, Inc.
|
- USD
|
-Infinity%
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Caribou Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
CRISPR Therapeutics AG
|
- USD
|
-Infinity%
|
|
Precision BioSciences, Inc.
|
- USD
|
-Infinity%
|
|
Dyadic International, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Eton Pharmaceuticals, Inc.
|
911 Thousand USD
|
48.875%
|
|
Fortress Biotech, Inc.
|
10.2 Million USD
|
95.437%
|
|
Lantern Pharma Inc.
|
- USD
|
-Infinity%
|
|
HOOKIPA Pharma Inc.
|
- USD
|
-Infinity%
|
|
Inhibikase Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Incyte Corporation
|
62.97 Million USD
|
99.26%
|
|
IO Biotech, Inc.
|
- USD
|
-Infinity%
|
|
Jaguar Health, Inc.
|
9.18 Million USD
|
94.931%
|
|
Novavax, Inc.
|
41.69 Million USD
|
98.883%
|
|
Janux Therapeutics, Inc.
|
-2.2 Million USD
|
121.17%
|
|
Opthea Limited
|
- USD
|
-Infinity%
|
|
Ligand Pharmaceuticals Incorporated
|
23.96 Million USD
|
98.057%
|
|
ContextLogic Inc.
|
- USD
|
-Infinity%
|
|
MiMedx Group, Inc.
|
21.02 Million USD
|
97.784%
|
|
Pyxis Oncology, Inc.
|
- USD
|
-Infinity%
|
|
TransCode Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
NextCure, Inc.
|
- USD
|
-Infinity%
|
|
Ocuphire Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Oncternal Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Outlook Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Vaxcyte, Inc.
|
-6.15 Million USD
|
107.562%
|
|
PDS Biotechnology Corporation
|
- USD
|
-Infinity%
|
|
Madrigal Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Pharming Group N.V.
|
56.76 Million USD
|
99.179%
|
|
Pieris Pharmaceuticals, Inc.
|
4.08 Million USD
|
88.604%
|
|
Avidity Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Sangamo Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Sol-Gel Technologies Ltd.
|
- USD
|
-Infinity%
|
|
Acelyrin, Inc.
|
8.85 Million USD
|
94.738%
|
|
Salarius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
SELLAS Life Sciences Group, Inc.
|
- USD
|
-Infinity%
|
|
Summit Therapeutics Inc.
|
2.44 Million USD
|
80.92%
|
|
Sensei Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Senti Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Stoke Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Syros Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Alaunos Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Telomir Pharmaceuticals, Inc. Common Stock
|
303.28 Thousand USD
|
-53.57%
|
|
Entrada Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
VistaGen Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Wave Life Sciences Ltd.
|
1.00 USD
|
-46574700.0%
|
|
Sorrento Therapeutics, Inc.
|
9.97 Million USD
|
95.331%
|
|
TRACON Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Barinthus Biotherapeutics plc
|
1.00 USD
|
-46574700.0%
|
|
Psyence Biomedical Ltd.
|
- USD
|
-Infinity%
|
|
Phathom Pharmaceuticals, Inc.
|
1.2 Million USD
|
61.445%
|
|
Immix Biopharma, Inc.
|
- USD
|
-Infinity%
|
|
Keros Therapeutics, Inc.
|
14.05 Million USD
|
96.686%
|
|
MEI Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Windtree Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Xeris Biopharma Holdings, Inc.
|
38.83 Million USD
|
98.801%
|
|
Rigel Pharmaceuticals, Inc.
|
5.52 Million USD
|
91.566%
|
|
Fortress Biotech, Inc.
|
10.2 Million USD
|
95.437%
|
|
Precigen, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Clearside Biomedical, Inc.
|
1.00 USD
|
-46574700.0%
|
|
AlloVir, Inc.
|
- USD
|
-Infinity%
|
|
C4 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Fate Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
ImmuCell Corporation
|
7.81 Million USD
|
94.038%
|
|
IDEAYA Biosciences, Inc.
|
532.61 Million USD
|
99.913%
|
|
Onconetix, Inc.
|
364.05 Thousand USD
|
-27.934%
|
|
PureTech Health plc
|
- USD
|
-Infinity%
|
|
VYNE Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Elevation Oncology, Inc.
|
- USD
|
-Infinity%
|
|
Kintara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Seer, Inc.
|
4.49 Million USD
|
89.629%
|
|
Verrica Pharmaceuticals Inc.
|
1.02 Million USD
|
54.428%
|
|
Innoviva, Inc.
|
40.73 Million USD
|
98.857%
|
|
Aadi Bioscience, Inc.
|
6.42 Million USD
|
92.753%
|
|
ESSA Pharma Inc.
|
- USD
|
-Infinity%
|
|
GlycoMimetics, Inc.
|
- USD
|
-Infinity%
|
|
GT Biopharma, Inc.
|
- USD
|
-Infinity%
|
|
Inhibrx Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Akebia Therapeutics, Inc.
|
15.69 Million USD
|
97.032%
|
|
Catalyst Pharmaceuticals, Inc.
|
15.64 Million USD
|
97.023%
|
|
Longboard Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Orchestra BioMed Holdings, Inc.
|
146 Thousand USD
|
-219.005%
|
|
Alzamend Neuro, Inc.
|
- USD
|
-Infinity%
|
|
Rocket Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Aptose Biosciences Inc.
|
- USD
|
-Infinity%
|
|
ZyVersa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Soligenix, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Century Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Kura Oncology, Inc.
|
- USD
|
-Infinity%
|
|
TScan Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Intensity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Ocean Biomedical, Inc.
|
- USD
|
-Infinity%
|
|
CytomX Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Autolus Therapeutics plc
|
-24.54 Million USD
|
101.898%
|
|
Mineralys Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
EyePoint Pharmaceuticals, Inc.
|
3.9 Million USD
|
88.076%
|
|
Eterna Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Adaptive Biotechnologies Corporation
|
14.44 Million USD
|
96.776%
|
|
GRI Bio, Inc.
|
- USD
|
-Infinity%
|
|
Xenetic Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Tenaya Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
IGM Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
INmune Bio, Inc.
|
- USD
|
-Infinity%
|
|
Heron Therapeutics, Inc.
|
42.11 Million USD
|
98.894%
|
|
SAB Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Pasithea Therapeutics Corp.
|
-40.5 Thousand USD
|
1249.995%
|
|
Entero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Milestone Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
X4 Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Atara Biotherapeutics, Inc.
|
9.7 Million USD
|
95.201%
|
|
Coherus BioSciences, Inc.
|
62.6 Million USD
|
99.256%
|
|
Verastem, Inc.
|
- USD
|
-Infinity%
|
|
Abeona Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Pliant Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Tonix Pharmaceuticals Holding Corp.
|
14.14 Million USD
|
96.708%
|
|
Histogen Inc.
|
400 Thousand USD
|
-16.437%
|
|
Aprea Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Surrozen, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Organovo Holdings, Inc.
|
297 Thousand USD
|
-56.818%
|
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Ovid Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Panbela Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
CASI Pharmaceuticals, Inc.
|
15.87 Million USD
|
97.067%
|
|
Cadrenal Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Centessa Pharmaceuticals plc
|
1.00 USD
|
-46574700.0%
|
|
Hepion Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Arcturus Therapeutics Holdings Inc.
|
1.00 USD
|
-46574700.0%
|
|
BioRestorative Therapies, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Apollomics, Inc.
|
-466 Thousand USD
|
199.946%
|
|
Amarin Corporation plc
|
258.61 Million USD
|
99.82%
|
|
Mesoblast Limited
|
- USD
|
-Infinity%
|
|
Turnstone Biologics Corp.
|
4.77 Million USD
|
90.238%
|
|
Kymera Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Synaptogenix, Inc.
|
- USD
|
-Infinity%
|
|
Tiziana Life Sciences Ltd
|
- USD
|
-Infinity%
|
|
Aurinia Pharmaceuticals Inc.
|
39.7 Million USD
|
98.827%
|
|
BriaCell Therapeutics Corp.
|
-1.36 Million USD
|
134.021%
|
|
Monopar Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Exelixis, Inc.
|
17.32 Million USD
|
97.311%
|
|
Better Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Nurix Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Apellis Pharmaceuticals, Inc.
|
146.36 Million USD
|
99.682%
|
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
|
Dermata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Aridis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Gritstone bio, Inc.
|
- USD
|
-Infinity%
|
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
TNF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Avid Bioservices, Inc.
|
30.37 Million USD
|
98.467%
|
|
Insmed Incorporated
|
83.24 Million USD
|
99.441%
|
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
MediWound Ltd.
|
2.84 Million USD
|
83.635%
|
|
OmniAb, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Alector, Inc.
|
- USD
|
-Infinity%
|
|
Seres Therapeutics, Inc.
|
29.64 Million USD
|
98.429%
|
|
Checkpoint Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Viracta Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Zai Lab Limited
|
44.82 Million USD
|
98.961%
|
|
Revance Therapeutics, Inc.
|
45.57 Million USD
|
98.978%
|
|
Aura Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Lyell Immunopharma, Inc.
|
- USD
|
-Infinity%
|
|
Immunic, Inc.
|
- USD
|
-Infinity%
|
|
Tarsus Pharmaceuticals, Inc.
|
3.1 Million USD
|
85.01%
|
|
Veracyte, Inc.
|
16.12 Million USD
|
97.112%
|
|
InMed Pharmaceuticals Inc.
|
1.24 Million USD
|
62.57%
|
|
FibroGen, Inc.
|
41.56 Million USD
|
98.879%
|
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
|
Adial Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Sonnet BioTherapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Jazz Pharmaceuticals plc
|
597.03 Million USD
|
99.922%
|
|
Cyclacel Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Amylyx Pharmaceuticals, Inc.
|
38.32 Million USD
|
98.785%
|
|
TG Therapeutics, Inc.
|
39.82 Million USD
|
98.83%
|
|
Galecto, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Calithera Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Fortrea Holdings Inc.
|
35.3 Million USD
|
98.681%
|
|
KalVista Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Aptevo Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
XBiotech Inc.
|
- USD
|
-Infinity%
|
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Lyra Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Foghorn Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Y-mAbs Therapeutics, Inc.
|
5.06 Million USD
|
90.805%
|
|
Theravance Biopharma, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Ultragenyx Pharmaceutical Inc.
|
33.96 Million USD
|
98.629%
|
|
Metagenomi, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Vaxxinity, Inc.
|
- USD
|
-Infinity%
|
|
BioCryst Pharmaceuticals, Inc.
|
28.68 Million USD
|
98.376%
|
|
Gain Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Cartesian Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
NexImmune, Inc.
|
- USD
|
-Infinity%
|
|
Creative Medical Technology Holdings, Inc.
|
6594.00 USD
|
-6963.209%
|
|
Marker Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Regeneron Pharmaceuticals, Inc.
|
2.58 Billion USD
|
99.982%
|
|
Chemomab Therapeutics Ltd.
|
-1.03 Million USD
|
144.913%
|
|
Scopus BioPharma Inc.
|
- USD
|
-Infinity%
|
|
RAPT Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Ainos, Inc.
|
167.59 Thousand USD
|
-177.904%
|
|
Pluri Inc.
|
222 Thousand USD
|
-109.796%
|
|
Prothena Corporation plc
|
-5.15 Million USD
|
109.028%
|
|
Adaptimmune Therapeutics plc
|
1.32 Million USD
|
64.955%
|
|
Celularity Inc.
|
5.75 Million USD
|
91.904%
|
|
Rallybio Corporation
|
- USD
|
-Infinity%
|
|
Cue Biopharma, Inc.
|
1.00 USD
|
-46574700.0%
|
|
MeiraGTx Holdings plc
|
- USD
|
-Infinity%
|
|
Omeros Corporation
|
8.58 Million USD
|
94.572%
|
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
|
Immunocore Holdings plc
|
4.5 Million USD
|
89.652%
|
|
Cocrystal Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Cidara Therapeutics, Inc.
|
6.09 Million USD
|
92.361%
|
|
Blueprint Medicines Corporation
|
21.22 Million USD
|
97.805%
|
|
CalciMedica, Inc.
|
- USD
|
-Infinity%
|
|
Cabaletta Bio, Inc.
|
- USD
|
-Infinity%
|
|
Marinus Pharmaceuticals, Inc.
|
2.41 Million USD
|
80.698%
|
|
Scholar Rock Holding Corporation
|
- USD
|
-Infinity%
|
|
Sana Biotechnology, Inc.
|
- USD
|
-Infinity%
|
|
Pulmatrix, Inc.
|
- USD
|
-Infinity%
|
|
Elicio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Vigil Neuroscience, Inc.
|
- USD
|
-Infinity%
|
|
Intellia Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Adlai Nortye Ltd. American Depositary Shares
|
1.00 USD
|
-46574700.0%
|
|
Cytokinetics, Incorporated
|
- USD
|
-Infinity%
|
|
Eloxx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Nutriband Inc.
|
168.6 Thousand USD
|
-176.236%
|
|
Protara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Vor Biopharma Inc.
|
- USD
|
-Infinity%
|
|
Roivant Sciences Ltd.
|
35.25 Million USD
|
98.679%
|
|
Evogene Ltd.
|
1.69 Million USD
|
72.49%
|
|
ProKidney Corp.
|
- USD
|
-Infinity%
|
|
Applied Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Hoth Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
BridgeBio Pharma, Inc.
|
16.65 Million USD
|
97.203%
|
|
CorMedix Inc.
|
2.1 Million USD
|
77.888%
|
|
BioLineRx Ltd.
|
1.95 Million USD
|
76.152%
|
|
Tango Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Galectin Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Atai Life Sciences N.V.
|
1.00 USD
|
-46574700.0%
|
|
Renovaro Biosciences Inc.
|
-439.31 Thousand USD
|
206.016%
|
|
Aerovate Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Zentalis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Sagimet Biosciences Inc.
|
- USD
|
-Infinity%
|
|
MediciNova, Inc.
|
- USD
|
-Infinity%
|
|
Praxis Precision Medicines, Inc.
|
- USD
|
-Infinity%
|
|
Cardio Diagnostics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
|
Axsome Therapeutics, Inc.
|
15.13 Million USD
|
96.923%
|
|
Biomea Fusion, Inc.
|
- USD
|
-Infinity%
|
|
PTC Therapeutics, Inc.
|
30.57 Million USD
|
98.477%
|
|
Mereo BioPharma Group plc
|
1.24 Million USD
|
62.651%
|
|
Cullinan Oncology, Inc.
|
-5.4 Million USD
|
108.625%
|
|
Syndax Pharmaceuticals, Inc.
|
2 Million USD
|
76.747%
|
|
Absci Corporation
|
- USD
|
-Infinity%
|
|
NRx Pharmaceuticals, Inc.
|
-6000.00 USD
|
7862.467%
|
|
4D Molecular Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Dyne Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Kiniksa Pharmaceuticals, Ltd.
|
31.12 Million USD
|
98.503%
|
|
Ventyx Biosciences, Inc.
|
-800 Thousand USD
|
158.219%
|
|
Allakos Inc.
|
- USD
|
-Infinity%
|
|
Imunon, Inc.
|
- USD
|
-Infinity%
|
|
Fulcrum Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Corcept Therapeutics Incorporated
|
7.73 Million USD
|
93.975%
|
|
BioAtla, Inc.
|
- USD
|
-Infinity%
|
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
|
Bio-Path Holdings, Inc.
|
632.00 USD
|
-73594.304%
|
|
Allogene Therapeutics, Inc.
|
-1.7 Million USD
|
127.397%
|
|
Larimar Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
XOMA Corporation
|
1.00 USD
|
-46574700.0%
|
|
Kezar Life Sciences, Inc.
|
- USD
|
-Infinity%
|
|
Cara Therapeutics, Inc.
|
2.82 Million USD
|
83.49%
|
|
aTyr Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Aligos Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Akero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Viridian Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Eliem Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
EyeGate Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Akari Therapeutics, Plc
|
- USD
|
-Infinity%
|
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
|
Halozyme Therapeutics, Inc.
|
127.6 Million USD
|
99.635%
|
|
Lexaria Bioscience Corp.
|
1.00 USD
|
-46574700.0%
|
|
UroGen Pharma Ltd.
|
5.67 Million USD
|
91.79%
|
|
Sutro Biopharma, Inc.
|
1.00 USD
|
-46574700.0%
|
|
ZIVO Bioscience, Inc.
|
- USD
|
-Infinity%
|
|
Orgenesis Inc.
|
34 Thousand USD
|
-1269.847%
|
|
Entera Bio Ltd.
|
- USD
|
-Infinity%
|
|
GH Research PLC
|
-178 Thousand USD
|
361.656%
|
|
Lisata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Reneo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Xencor, Inc.
|
-11.29 Million USD
|
104.125%
|
|
60 Degrees Pharmaceuticals, Inc.
|
466.16 Thousand USD
|
0.09%
|
|
Replimune Group, Inc.
|
- USD
|
-Infinity%
|
|
Coeptis Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Vanda Pharmaceuticals Inc.
|
1.35 Million USD
|
65.678%
|
|
Lexaria Bioscience Corp.
|
1.00 USD
|
-46574700.0%
|
|
Portage Biotech Inc.
|
- USD
|
-Infinity%
|
|
Cardio Diagnostics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Olema Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
OncoCyte Corporation
|
- USD
|
-Infinity%
|
|
Qualigen Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Processa Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Purple Biotech Ltd.
|
- USD
|
-Infinity%
|
|
CollPlant Biotechnologies Ltd.
|
714 Thousand USD
|
34.769%
|
|
scPharmaceuticals Inc.
|
8.84 Million USD
|
94.731%
|
|
ProMIS Neurosciences, Inc.
|
- USD
|
-Infinity%
|
|
HilleVax, Inc.
|
- USD
|
-Infinity%
|
|
NeuroSense Therapeutics Ltd.
|
- USD
|
-Infinity%
|
|
Tharimmune, Inc.
|
- USD
|
-Infinity%
|
|
Genprex, Inc.
|
- USD
|
-Infinity%
|
|
Neumora Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Atossa Therapeutics, Inc.
|
1.48 Million USD
|
68.679%
|
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
|
Virios Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
OKYO Pharma Limited
|
- USD
|
-Infinity%
|
|
Savara Inc.
|
1.00 USD
|
-46574700.0%
|
|
Curis, Inc.
|
- USD
|
-Infinity%
|
|
Daré Bioscience, Inc.
|
- USD
|
-Infinity%
|
|
Carmell Therapeutics Corporation
|
- USD
|
-Infinity%
|
|
Titan Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Achieve Life Sciences, Inc.
|
- USD
|
-Infinity%
|
|
BeiGene, Ltd.
|
416.12 Million USD
|
99.888%
|
|
Kiromic BioPharma, Inc.
|
- USD
|
-Infinity%
|
|
Revolution Medicines, Inc. Warrant
|
1.00 USD
|
-46574700.0%
|
|
Protagonist Therapeutics, Inc.
|
-10.33 Million USD
|
104.508%
|
|
Erasca, Inc.
|
- USD
|
-Infinity%
|
|
bluebird bio, Inc.
|
22.91 Million USD
|
97.968%
|
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
BioMarin Pharmaceutical Inc.
|
1.1 Billion USD
|
99.958%
|
|
DBV Technologies S.A.
|
- USD
|
-Infinity%
|
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Moderna, Inc.
|
202 Million USD
|
99.769%
|
|
Vincerx Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Fresh Tracks Therapeutics, Inc.
|
545 Thousand USD
|
14.542%
|
|
Molecular Templates, Inc.
|
- USD
|
-Infinity%
|
|
Acrivon Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Travere Therapeutics, Inc.
|
9.41 Million USD
|
95.05%
|
|
Monte Rosa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Spruce Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Celldex Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Cogent Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
MacroGenics, Inc.
|
1.22 Million USD
|
61.855%
|
|
RenovoRx, Inc.
|
- USD
|
-Infinity%
|
|
Adicet Bio, Inc.
|
- USD
|
-Infinity%
|
|
Prime Medicine, Inc.
|
- USD
|
-Infinity%
|
|
Aditxt, Inc.
|
745.5 Thousand USD
|
37.526%
|
|
Adagene Inc.
|
- USD
|
-Infinity%
|
|
Estrella Immunopharma, Inc.
|
-288.76 Thousand USD
|
261.292%
|
|
Quantum-Si incorporated
|
3.94 Million USD
|
88.194%
|
|
Maravai LifeSciences Holdings, Inc.
|
51.39 Million USD
|
99.094%
|
|
Acurx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Voyager Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
SciSparc Ltd.
|
742 Thousand USD
|
37.231%
|
|
Vericel Corporation
|
13.08 Million USD
|
96.441%
|
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Minerva Neurosciences, Inc.
|
- USD
|
-Infinity%
|
|
Generation Bio Co.
|
3.81 Million USD
|
87.795%
|
|
Astria Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Black Diamond Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Arcutis Biotherapeutics, Inc.
|
13.13 Million USD
|
96.454%
|
|
Invivyd, Inc.
|
- USD
|
-Infinity%
|
|
Relay Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Quoin Pharmaceuticals, Ltd.
|
- USD
|
-Infinity%
|
|
Spero Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Artelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
2seventy bio, Inc.
|
-13.41 Million USD
|
103.473%
|
|
ADMA Biologics, Inc.
|
172.9 Million USD
|
99.731%
|
|
Clene Inc.
|
37 Thousand USD
|
-1158.778%
|
|
Capricor Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Boundless Bio, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
|
Recursion Pharmaceuticals, Inc.
|
-3.09 Million USD
|
115.053%
|
|
Citius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Contineum Therapeutics, Inc. Class A Common Stock
|
- USD
|
-Infinity%
|
|
Relmada Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Finch Therapeutics Group, Inc.
|
- USD
|
-Infinity%
|
|
ALX Oncology Holdings Inc.
|
- USD
|
-Infinity%
|
|
Vir Biotechnology, Inc.
|
- USD
|
-Infinity%
|
|
Evaxion Biotech A/S
|
- USD
|
-Infinity%
|
|
Ocular Therapeutix, Inc.
|
2.3 Million USD
|
79.794%
|
|
Verve Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Trevena, Inc.
|
- USD
|
-Infinity%
|
|
Surrozen, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Tyra Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Cingulate Inc.
|
-14.62 Thousand USD
|
3285.255%
|
|
Galmed Pharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
|
Unity Biotechnology, Inc.
|
- USD
|
-Infinity%
|
|
Tenax Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Terns Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
ACADIA Pharmaceuticals Inc.
|
35.81 Million USD
|
98.7%
|
|
Connect Biopharma Holdings Limited
|
-13.95 Million USD
|
103.339%
|
|
Clearmind Medicine Inc.
|
-11.39 Thousand USD
|
4187.624%
|
|
Kronos Bio, Inc.
|
- USD
|
-Infinity%
|
|
Bolt Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Viking Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Statera Biopharma, Inc.
|
1.8 Million USD
|
74.23%
|
|
ImmunityBio, Inc.
|
- USD
|
-Infinity%
|
|
Korro Bio, Inc.
|
- USD
|
-Infinity%
|
|
Kineta, Inc.
|
- USD
|
-Infinity%
|
|
BioVie Inc.
|
- USD
|
-Infinity%
|
|
Codexis, Inc.
|
2.68 Million USD
|
82.654%
|
|
Celularity Inc.
|
5.75 Million USD
|
91.904%
|
|
Crinetics Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Celcuity Inc.
|
- USD
|
-Infinity%
|
|
Virax Biolabs Group Limited
|
60.38 Thousand USD
|
-671.323%
|
|
Cibus, Inc.
|
- USD
|
-Infinity%
|
|
Eledon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
eFFECTOR Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
IN8bio, Inc.
|
- USD
|
-Infinity%
|
|
Kodiak Sciences Inc.
|
- USD
|
-Infinity%
|
|
Annexon, Inc.
|
- USD
|
-Infinity%
|
|
Adverum Biotechnologies, Inc.
|
- USD
|
-Infinity%
|
|
Assembly Biosciences, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Avalo Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Ionis Pharmaceuticals, Inc.
|
28.42 Million USD
|
98.361%
|
|
Eyenovia, Inc.
|
109.79 Thousand USD
|
-324.186%
|
|
Puma Biotechnology, Inc.
|
7.08 Million USD
|
93.422%
|
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
Xilio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Arcellx, Inc.
|
- USD
|
-Infinity%
|
|
Cardiff Oncology, Inc.
|
- USD
|
-Infinity%
|
|
Enanta Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Regulus Therapeutics Inc.
|
3010.00 USD
|
-15373.355%
|
|
Acumen Pharmaceuticals, Inc.
|
98 Thousand USD
|
-375.253%
|
|
Geron Corporation
|
- USD
|
-Infinity%
|
|
LAVA Therapeutics N.V.
|
- USD
|
-Infinity%
|
|
Royalty Pharma plc
|
- USD
|
-Infinity%
|
|
Atea Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Greenwich LifeSciences, Inc.
|
- USD
|
-Infinity%
|
|
TFF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Mersana Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
|
Structure Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
89bio, Inc.
|
- USD
|
-Infinity%
|
|
PMV Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Avenue Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Genelux Corporation
|
- USD
|
-Infinity%
|
|
Trevi Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Lexicon Pharmaceuticals, Inc.
|
381 Thousand USD
|
-22.244%
|
|
Notable Labs, Ltd.
|
2.88 Million USD
|
83.867%
|
|
Liquidia Corporation
|
1.00 USD
|
-46574700.0%
|
|
Mustang Bio, Inc.
|
- USD
|
-Infinity%
|
|
Immunovant, Inc.
|
- USD
|
-Infinity%
|
|
Quantum-Si incorporated
|
3.94 Million USD
|
88.194%
|
|
Arbutus Biopharma Corporation
|
-1.77 Million USD
|
126.225%
|
|
DiaMedica Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Vera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Acasti Pharma Inc.
|
- USD
|
-Infinity%
|
|
MiNK Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Pasithea Therapeutics Corp.
|
-40.5 Thousand USD
|
1249.995%
|
|
Xenon Pharmaceuticals Inc.
|
1.00 USD
|
-46574700.0%
|
|
Elevai Labs, Inc. Common Stock
|
598.78 Thousand USD
|
22.218%
|
|
NeuroBo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Tempest Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Soleno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
PepGen Inc.
|
- USD
|
-Infinity%
|
|
Moleculin Biotech, Inc.
|
- USD
|
-Infinity%
|
|
United Therapeutics Corporation
|
111.8 Million USD
|
99.583%
|
|
Nuvectis Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Solid Biosciences Inc.
|
- USD
|
-Infinity%
|
|
BriaCell Therapeutics Corp.
|
-1.36 Million USD
|
134.006%
|
|
Immuneering Corporation
|
- USD
|
-Infinity%
|
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Silo Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Belite Bio, Inc
|
- USD
|
-Infinity%
|
|
XOMA Corporation
|
1.00 USD
|
-46574700.0%
|
|
ARS Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Bionomics Limited
|
-458.3 Million USD
|
100.102%
|
|
Apogee Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
|
uniQure N.V.
|
12.02 Million USD
|
96.127%
|
|
Cassava Sciences, Inc.
|
- USD
|
-Infinity%
|
|
Estrella Immunopharma, Inc.
|
-288.76 Thousand USD
|
261.292%
|
|
Poseida Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Forte Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Enlivex Therapeutics Ltd.
|
-229 Thousand USD
|
303.383%
|
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
|
FibroBiologics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Altimmune, Inc.
|
- USD
|
-Infinity%
|
|
Amicus Therapeutics, Inc.
|
59.69 Million USD
|
99.22%
|
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
|
Compugen Ltd.
|
- USD
|
-Infinity%
|
|
Peak Bio, Inc.
|
1.91 Million USD
|
75.706%
|
|
Zevra Therapeutics, Inc.
|
9.84 Million USD
|
95.267%
|
|
Benitec Biopharma Inc.
|
63 Thousand USD
|
-639.283%
|
|
Spyre Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
NKGen Biotech, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Zura Bio Limited
|
- USD
|
-Infinity%
|
|
PolyPid Ltd.
|
- USD
|
-Infinity%
|
|
Aileron Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
NKGen Biotech, Inc. Warrants
|
- USD
|
-Infinity%
|
|
Instil Bio, Inc.
|
- USD
|
-Infinity%
|
|
argenx SE
|
310.55 Million USD
|
99.85%
|
|
Immunome, Inc.
|
- USD
|
-Infinity%
|
|
Compass Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Verona Pharma plc
|
1.00 USD
|
-46574700.0%
|
|
enGene Holdings Inc. Warrants
|
76 Thousand USD
|
-512.826%
|
|
Shattuck Labs, Inc.
|
- USD
|
-Infinity%
|
|
CervoMed Inc.
|
- USD
|
-Infinity%
|
|
LENZ Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Plus Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Dianthus Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Moolec Science SA
|
465.74 Thousand USD
|
0.0%
|
|
Enveric Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Inovio Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
AnaptysBio, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Design Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Leap Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
NeurAxis, Inc.
|
21.22 Thousand USD
|
-2094.854%
|
|
Seelos Therapeutics, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Lumos Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Achilles Therapeutics plc
|
1.00 USD
|
-46574700.0%
|
|
enGene Holdings Inc. Common Stock
|
76 Thousand USD
|
-512.826%
|
|
180 Life Sciences Corp.
|
- USD
|
-Infinity%
|
|
Opiant Pharmaceuticals, Inc.
|
-2.95 Billion USD
|
100.016%
|
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Nutriband Inc.
|
168.6 Thousand USD
|
-176.236%
|
|
ORIC Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
CG Oncology, Inc. Common stock
|
- USD
|
-Infinity%
|
|
Fractyl Health, Inc. Common Stock
|
73 Thousand USD
|
-538.011%
|
|
Rani Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
MoonLake Immunotherapeutics
|
- USD
|
-Infinity%
|
|
Palisade Bio, Inc.
|
- USD
|
-Infinity%
|
|
Tourmaline Bio, Inc.
|
- USD
|
-Infinity%
|
|
Beam Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Neurogene Inc.
|
1.49 Million USD
|
68.867%
|
|
Mirum Pharmaceuticals, Inc.
|
22.31 Million USD
|
97.913%
|
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
|
CARGO Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Sesen Bio, Inc.
|
21 Million USD
|
97.782%
|
|
Enliven Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Kiora Pharmaceuticals, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Iovance Biotherapeutics, Inc.
|
10.37 Million USD
|
95.51%
|
|
Taysha Gene Therapies, Inc.
|
- USD
|
-Infinity%
|
|
Athira Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Vaccinex, Inc.
|
- USD
|
-Infinity%
|
|
HCW Biologics Inc.
|
- USD
|
-Infinity%
|
|
XOMA Corporation
|
1.00 USD
|
-46574700.0%
|
|
Nektar Therapeutics
|
16.1 Million USD
|
97.107%
|
|
Arvinas, Inc.
|
- USD
|
-Infinity%
|
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
|
Merus N.V.
|
1.00 USD
|
-46574700.0%
|
|
Omega Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Quince Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Rezolute, Inc.
|
- USD
|
-Infinity%
|
|
Clene Inc.
|
37 Thousand USD
|
-1158.778%
|
|
Indaptus Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
BeyondSpring Inc.
|
- USD
|
-Infinity%
|
|
Synlogic, Inc.
|
- USD
|
-Infinity%
|
|
Allarity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Phio Pharmaceuticals Corp.
|
- USD
|
-Infinity%
|
|
Peak Bio, Inc.
|
1.91 Million USD
|
75.706%
|
|
Werewolf Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Krystal Biotech, Inc.
|
6.98 Million USD
|
93.332%
|
|
Karyopharm Therapeutics Inc.
|
3.04 Million USD
|
84.694%
|
|
SpringWorks Therapeutics, Inc.
|
3.1 Million USD
|
84.99%
|
|
Lipella Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
MannKind Corporation
|
28.54 Million USD
|
98.368%
|
|
Ikena Oncology, Inc.
|
- USD
|
-Infinity%
|
|
Cyclerion Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Gyre Therapeutics, Inc.
|
4.28 Million USD
|
89.121%
|
|
Gossamer Bio, Inc.
|
- USD
|
-Infinity%
|
|
CohBar, Inc.
|
- USD
|
-Infinity%
|
|
Cognition Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
NRx Pharmaceuticals, Inc.
|
-6000.00 USD
|
7862.467%
|
|
Legend Biotech Corporation
|
19.43 Million USD
|
97.603%
|
|
Mural Oncology plc
|
150 Thousand USD
|
-210.499%
|
|
Biora Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
PaxMedica, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Disc Medicine, Inc.
|
- USD
|
-Infinity%
|
|
Champions Oncology, Inc.
|
1.00 USD
|
-46574700.0%
|
|
REGENXBIO Inc.
|
- USD
|
-Infinity%
|
|
Ensysce Biosciences, Inc.
|
-97.56 Thousand USD
|
577.392%
|
|
Anavex Life Sciences Corp.
|
- USD
|
-Infinity%
|
|
Cellectar Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Edgewise Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Vaxart, Inc.
|
1.00 USD
|
-46574700.0%
|
|
PharmaCyte Biotech, Inc.
|
- USD
|
-Infinity%
|
|
Aldeyra Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Cellectis S.A.
|
- USD
|
-Infinity%
|
|
Longeveron Inc.
|
- USD
|
-Infinity%
|
|
Repare Therapeutics Inc.
|
2.00 USD
|
-23287300.0%
|
|
Sarepta Therapeutics, Inc.
|
322.85 Million USD
|
99.856%
|
|
Inozyme Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Revolution Medicines, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Nymox Pharmaceutical Corporation
|
28 Thousand USD
|
-1563.386%
|
|
Third Harmonic Bio, Inc.
|
- USD
|
-Infinity%
|
|
ArriVent BioPharma, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
AN2 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Anixa Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Vertex Pharmaceuticals Incorporated
|
738.8 Million USD
|
99.937%
|
|
Denali Therapeutics Inc.
|
1.00 USD
|
-46574700.0%
|
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Veru Inc.
|
6.69 Million USD
|
93.046%
|
|
Corvus Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Cingulate Inc.
|
-14.62 Thousand USD
|
3285.255%
|
|
Passage Bio, Inc.
|
- USD
|
-Infinity%
|
|
Context Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Exicure, Inc.
|
- USD
|
-Infinity%
|
|
Day One Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Oramed Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
Scinai Immunotherapeutics Ltd.
|
-1.87 Million USD
|
124.846%
|
|
Rhythm Pharmaceuticals, Inc.
|
8.62 Million USD
|
94.599%
|
|
Nuvalent, Inc.
|
- USD
|
-Infinity%
|
|
ABVC BioPharma, Inc.
|
- USD
|
-Infinity%
|
|
Carisma Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Unicycive Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
OmniAb, Inc.
|
1.00 USD
|
-46574700.0%
|
|
Anew Medical, Inc.
|
- USD
|
-Infinity%
|
|
Fennec Pharmaceuticals Inc.
|
2.14 Million USD
|
78.286%
|
|
Lipocine Inc.
|
- USD
|
-Infinity%
|
|
Lexeo Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Nautilus Biotechnology, Inc.
|
- USD
|
-Infinity%
|
|
SAB Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
|
G1 Therapeutics, Inc.
|
12.44 Million USD
|
96.257%
|
|
Bellerophon Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Sage Therapeutics, Inc.
|
1.33 Million USD
|
65.034%
|
|
Ocugen, Inc.
|
- USD
|
-Infinity%
|
|
Mind Medicine (MindMed) Inc.
|
- USD
|
-Infinity%
|
|
Q32 Bio Inc.
|
- USD
|
-Infinity%
|
|
Brainstorm Cell Therapeutics Inc.
|
-51 Thousand USD
|
1013.231%
|
|
Alumis Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Equillium, Inc.
|
- USD
|
-Infinity%
|
|
Kyverna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Coya Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
CNS Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Galera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Evelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Comera Life Sciences Holdings, Inc.
|
2.5 Million USD
|
81.439%
|
|
Dominari Holdings Inc.
|
1.00 USD
|
-46574700.0%
|
|
Edesa Biotech, Inc.
|
- USD
|
-Infinity%
|
|
vTv Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Bio-Techne Corporation
|
179.73 Million USD
|
99.741%
|
|
Agios Pharmaceuticals, Inc.
|
19.07 Million USD
|
97.558%
|
|
Harmony Biosciences Holdings, Inc.
|
5.36 Million USD
|
91.316%
|
|
Prelude Therapeutics Incorporated
|
- USD
|
-Infinity%
|
|
Candel Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
iTeos Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Nkarta, Inc.
|
- USD
|
-Infinity%
|
|
BioCardia, Inc.
|
- USD
|
-Infinity%
|
|
Iterum Therapeutics plc
|
- USD
|
-Infinity%
|
